UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity

The Journal of pharmacology and experimental therapeutics, 2005-05, Vol.313 (2), p.862-869

2005

Volltextzugriff (PDF)

Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT6 Receptor Agonists and Antagonists

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.353-356

2005

Volltextzugriff (PDF)

The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2,4,5,6-tetrahydropyrazolo-[3,4-d]thieno[3,2-b]azepines

Bioorganic & medicinal chemistry letters, 2000-04, Vol.10 (8), p.695-698

2000

Volltextzugriff (PDF)

Integrating system dynamics and fuzzy bargaining for quantitative risk allocation in construction projects

Scientia Iranica. Transaction A, Civil engineering, 2015-06, Vol.22 (3), p.668

2015

Volltextzugriff (PDF)

5-fluoro-2-methyl-N-[5-(5 H-pyrrolo[2,1- c][1,4]benzodiazepine-10(11 H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (13), p.1737-1740

1999

Volltextzugriff (PDF)

4,10-Dihydro-5h-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4h-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (13), p.1733-1736

1999

Volltextzugriff (PDF)

5-Fluoro-2-methyl- N -[4-(5 H -pyrrolo[2,1- c ]- [1,4]benzodiazepin-10(11 H )-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V 2 Receptors

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2442-2444

1998

Volltextzugriff (PDF)

Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists

Bioorganic & medicinal chemistry letters, 2003-07, Vol.13 (13), p.2195-2198

2003

Volltextzugriff (PDF)

Computational Efficient Brain PET Image Denoising by Diffusion Probabilistic Models

2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor Detectors (NSS MIC RTSD), 2023, p.1-1

2023

Volltextzugriff (PDF)

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V2 Receptors

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2442-2444

1998

Volltextzugriff (PDF)

(4-Substituted-phenyl)-(5 H-10,11-dihydro-pyrrolo [2,1- c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators

Bioorganic & medicinal chemistry letters, 2005-11, Vol.15 (22), p.5003-5006

2005

Volltextzugriff (PDF)

Alterations of bromocriptine-induced penile erection by chronic lithium in rats

Journal of psychopharmacology (Oxford), 1996-01, Vol.10 (2), p.157-161

1996

Volltextzugriff (PDF)

Antiobesity-like effects of the 5-HT sub(2) sub(C) receptor agonist WAY-161503

Brain research, 2006-02, Vol.1073-1074, p.240-251

2006

Volltextzugriff (PDF)

P.2.126 Pharmacological evaluation of D2 partial agonists: Coupling D2 RS to Gαq/o and Gαq/i chimeras in CHO-K1 cells

European neuropsychopharmacology, 2004-10, Vol.14, p.S287-S288

2004

Volltextzugriff (PDF)

Discovery of 5-Arylsulfonamido-3-(pyrrolidin-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT sub(6) Receptor Agonists and Antagonists

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.353-356

2005

Volltextzugriff (PDF)

Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a, 5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines

Bioorganic & medicinal chemistry letters, 2000-09, Vol.10 (17), p.1991-1994

2000

Volltextzugriff (PDF)

VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist

Advances in experimental medicine and biology, 1998, Vol.449, p.439

1998

Volltextzugriff (PDF)

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

Journal of medicinal chemistry, 1997-12, Vol.40 (26), p.4235-4256

1997

Volltextzugriff (PDF)

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D 2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

Journal of medicinal chemistry, 1997-12, Vol.40 (26), p.4235-4256

1997

Volltextzugriff (PDF)

New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D 2 template

Bioorganic & medicinal chemistry letters, 1999-09, Vol.9 (17), p.2593-2598

1999

Volltextzugriff (PDF)

New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives

Tetrahedron, 1998-06, Vol.54 (25), p.7081-7108

1998

Volltextzugriff (PDF)

New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D2 template

Bioorganic & medicinal chemistry letters, 1999-09, Vol.9 (17), p.2593-2598

1999

Volltextzugriff (PDF)

4,10-dihydro-5 H-thieno[3,2- c][1]benzazepine derivatives and 9,10-dihydro-4 H-thieno[2,3- c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists

Bioorganic & medicinal chemistry letters, 1999, Vol.9 (13), p.1733-1736

1999

Volltextzugriff (PDF)

New generation dopaminergic agents. 5. heterocyclic bioisosteres that exploit the 3-OH- N1-phenylpiperazine dopaminergic template

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (19), p.2675-2680

1998

Volltextzugriff (PDF)

Effects of chronic lithium pretreatment on apomorphine-induced penile erection

General pharmacology, 1995-09, Vol.26 (5), p.1015-1020

1995

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(56)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(17)
Animals
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Pharmacology & Pharmacy
(14)
Pharmacology. Drug Treatments
(14)
Physical Sciences
(13)
Chemistry, Medicinal
(11)
Neuropharmacology
(11)
Rats
(11)
Structure-Activity Relationship
(11)
Chemistry
(10)
Neurotransmitters. Neurotransmission. Receptors
(10)
Chemistry, Organic
(9)
Humans
(7)
Azepines - Pharmacology
(6)
Medicinal Chemistry
(6)
Pharmacology
(6)
Pharmacology, Medicinal Chemistry, Vaccines, Serums
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity

Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT6 Receptor Agonists and Antagonists

The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2,4,5,6-tetrahydropyrazolo-[3,4-d]thieno[3,2-b]azepines

Integrating system dynamics and fuzzy bargaining for quantitative risk allocation in construction projects

5-fluoro-2-methyl-N-[5-(5 H-pyrrolo[2,1- c][1,4]benzodiazepine-10(11 H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists

4,10-Dihydro-5h-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4h-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists

5-Fluoro-2-methyl- N -[4-(5 H -pyrrolo[2,1- c ]- [1,4]benzodiazepin-10(11 H )-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V 2 Receptors

Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists

Computational Efficient Brain PET Image Denoising by Diffusion Probabilistic Models

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V2 Receptors

(4-Substituted-phenyl)-(5 H-10,11-dihydro-pyrrolo [2,1- c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators

Alterations of bromocriptine-induced penile erection by chronic lithium in rats

Antiobesity-like effects of the 5-HT sub(2) sub(C) receptor agonist WAY-161503

P.2.126 Pharmacological evaluation of D2 partial agonists: Coupling D2 RS to Gαq/o and Gαq/i chimeras in CHO-K1 cells

Discovery of 5-Arylsulfonamido-3-(pyrrolidin-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT sub(6) Receptor Agonists and Antagonists

Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a, 5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines

VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D 2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D 2 template

New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives

New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D2 template

4,10-dihydro-5 H-thieno[3,2- c][1]benzazepine derivatives and 9,10-dihydro-4 H-thieno[2,3- c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists

New generation dopaminergic agents. 5. heterocyclic bioisosteres that exploit the 3-OH- N1-phenylpiperazine dopaminergic template

Effects of chronic lithium pretreatment on apomorphine-induced penile erection

Suchergebnisse filtern